Benzinga | Nov 12, 2020 04:14PM EST

NGM Biopharmaceuticals Q3 EPS $(0.43) Down From $(0.17) YoY, Sales $23.48M Up From $21.57M YoY

NGM Biopharmaceuticals (NASDAQ:NGM) reported quarterly losses of $(0.43) per share. This is a 152.94 percent decrease over losses of $(0.17) per share from the same period last year. The company reported $23.48 million in sales this quarter. This is a 8.87 percent increase over sales of $21.57 million the same period last year.